MARKET

GCVRZ

Sanofi FR
GCVRZ
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
0.3341
0.0258
0.0165
1,088,892,353.18
Sanofi lowered to Neutral at UBS on lack of catalysts, lower growth
UBS downgraded the French drugmaker Sanofi (NASDAQ:SNY) (<a href="https://s...
Seekingalpha · 1d ago
BUZZ-China's Innovent Biologics jumps most in 6 weeks on Sanofi's investment
BUZZ-China's Innovent Biologics jumps most in 6 weeks on Sanofi's investment
Reuters · 6d ago
BRIEF-Innovent Biologics Announces Agreements With Sanofi
BRIEF-Innovent Biologics Announces Agreements With Sanofi
Reuters · 6d ago
Sanofi lifts profit outlook as Dupixent sales surge over 43%
Sanofi lifts profit outlook as Dupixent sales surge over 43%
Reuters · 07/28 05:30
BRIEF-Regeneron Pharmaceuticals Says Dupixent® (Dupilumab) Phase 3 Trial Shows Positive Results In Children Aged 1 To 11 Years With Eosinophilic Esophagitis
BRIEF-Regeneron Pharmaceuticals Says Dupixent® (Dupilumab) Phase 3 Trial Shows Positive Results In Children Aged 1 To 11 Years With Eosinophilic Esophagitis
Reuters · 07/14 05:04
UPDATE 1-Wacker Chemie invests 100 million euros in mRNA factory
UPDATE 1-Wacker Chemie invests 100 million euros in mRNA factory
Reuters · 07/05 13:08
BRIEF-Skyhawk Partners With Sanofi On Oncology And Immunology Targets
BRIEF-Skyhawk Partners With Sanofi On Oncology And Immunology Targets
Reuters · 07/05 12:10
BRIEF-Regeneron Completes Purchase Of Sanofi's Stake In Libtayo (Cemiplimab)
BRIEF-Regeneron Completes Purchase Of Sanofi's Stake In Libtayo (Cemiplimab)
Reuters · 07/01 11:21
More
No Data
Learn about the latest financial forecast of GCVRZ. Analyze the recent business situations of Sanofi FR through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.30%
Pharmaceuticals & Medical Research
+0.92%
Key Executives
Chairman/Independent Director
Serge Weinberg
Chairman - Management/Chief Executive Officer/Executive Board/Director
Olivier Brandicourt
Chief Financial Officer/Executive Vice President/Executive Board
Jerome Contamine
Executive Vice President/General Counsel/Executive Board
Karen Linehan
Executive Vice President/Director of Human Resources/Executive Board
Roberto Pucci
Executive Vice President/Executive Board
Dominique Carouge
Executive Vice President/Executive Board
Olivier Charmeil
Executive Vice President/Executive Board
Peter Guenter
Executive Vice President/Executive Board
David Loew
Executive Vice President/Executive Board
Philippe Luscan
Executive Vice President/Executive Board
Alan Main
Director
Laurent Attal
Director
Christian Mulliez
Independent Director
Emmanuel Babeau
Independent Director
Bernard Charles
Independent Director
Claudie Haignere
Independent Director
Patrick Kron
No Data
No Data

Webull offers kinds of Sanofi FR stock information, including NASDAQ:GCVRZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GCVRZ stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading GCVRZ stock methods without spending real money on the virtual paper trading platform.